Relation between morbidity and current treatment in patients who present with acute asthma to polyclinics

Singapore Medical Journal

Volumn 41, Issue 6, 2000, Pages 259-263

  Tan, N C ^a   Goh, S ^a   Leong, H ^a   Ng, C J ^a   Thai, V ^a   Siew, W F ^a   Emmanuel, S ^a   Lim, T K ^b  

^a MINISTRY OF HEALTH   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Asthma; Guidelines; Morbidity; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; EMERGENCY TREATMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; SINGAPORE;

ACUTE DISEASE; ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ASTHMA; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SINGAPORE; TREATMENT OUTCOME;

EID: 0342521534     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ng TP, Hui KP, Tan WC. Prevalence of asthma and risk factors among Chinese, Malay, and Indian adults in Singapore. Thorax 1994; 49:347-351.
2. Goh DYT, Chew FT, Quek SC, Lee BW. Prevalence and severity of asthma, rhinitis and eczema in Singapore children. Arch Dis Child 1996; 74:131-135
3. Chew FT, Lee BW. Utilization of health care resources for asthma
4. Chew FT, Goh DYT, Lee BW. The economic cost of asthma in Singapore. Aust NZ J 1999; 29:228-223.
5. Smith DH, Malone DC, Lawson KA, Okamato LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156:787-93.
6. Lim TK. Acute bronchial asthma: A pattern of admissions. Singapore Med J 1984;27:464-6.
7. Abisheganaden J, KN Sin Fai Lam, TK Lim. A profile of acute asthma patients presenting to the emergency room. Singapore Med J 1996; 37:252254.
8. Tough SC, Hessel PA, Ruff M, Green FH, Mitchell I, Butt JC. Features that distinguish those who die from asthma from community controls with asthma. J Asthma 1998; 35:657-65.
9. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and treatment of asthma. Bathesda, Md:NIH, Pub 1997; 55-4501.
10. Family Health Service, Ministry of Health (Singapore) Annual Report 1998.
11. Fix A, Sextton M, Langenberg P, Santanello N, Hyndman S, William R. The association of nocturnal asthma with asthma severity. Journal Asthma 1997; 34(4):329-336.
12. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364-369.
13. Fireman P. Beta 2 agonists and their safety in the treatment of asthma. Allergy Proc 1995; 16:235-239.
14. Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, et al. Randomised trial of an inhaled 2 agonist, inhaled corticosteroid and their combinat on in the treatment of asthma. Thorax 1999; 54:482487.
15. Simon RA. Update on inhaled corticosteroid: safety, compliance and new delivery systems. Allergy Proc. 1999; 20:161-165.
16. The British Guidelines on Asthma Management, 1995 review and position statement. Thorax 1997 Feb; 52:Supplemcnt 1.
17. Horn CR, Cochrane GM. Management of asthma in general practice. Respiratory Medicine 1989;83 :67-70
18. Tina V, Hartet, Windom HH, Peebles RS, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. The American Journal of Medicine 1996; 100:386-394.
19. Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, and Tattersfield AE. Morbidity from asthma in relation to regular treatment: a community based study Thorax 1999; 54:296-300.
20. Kips JC, Peleman RA, Pauwels RA. Role of theophyllines in asthma management. Curr Opinion in Pul 1999; 5:88-92.